Having sold Belgravia House – its Westminster offices since 1995 – to a private investor in March 2021 for £14.5m, RCVS Council agreed the purchase of the new building for £20.5m.
The additional cost has been funded from College reserves.
The new building is a converted Victorian warehouse with open-plan office space spread across six floors.
The new premises are large enough to accommodate more staff and for the College to host more meetings and events.
Alternatively, the space can be used for greater social distancing and hybrid working if needed.
The College says any unwanted space can be rented out.
Two existing tenants will continue to lease office space at the premises for the time being and some refurbishment work will need to be completed before the College and RCVS Knowledge teams can start moving in.
Following Council’s earlier decision to terminate the lease on Belgravia House at the end of March 2022, RCVS staff will continue to work either remotely, or in temporary office space leased from the workplace provider, WeWork, in Chancery Lane.
The College says this arrangement offers a significant saving over leasing back Belgravia House.
Chief Executive Lizzie Lockett said: “Like any property purchase, it has been an extremely long and difficult journey to get to this point, with many challenges to navigate along the way, but I am delighted that we are finally able to announce our new home.
“Whilst we will have to wait a while longer before we can enjoy everything 1-2 Hardwick Street has to offer, we are very much looking forward to welcoming members of the professions to visit our new offices, and being able to host a variety of meetings and new events there for them.
David, who graduated at Bristol in 2019, worked in mixed practice before joining Scarsdale Vets’ farm animal team early in 2020, where he developed a passion for small ruminant work and completed his CertAVP (Sheep).
He went on to relaunch the ‘flock health club’ and secured funding for new advanced breeding services to support sheep farms across the Midlands.
After sustaining significant injuries in a serious car accident, he was forced to step down from clinical work but went on to set up his veterinary consultancy, offering CPD training for vets and students working with The Webinar Vet and Vet Times.
This year, he joined NoBACZ Healthcare as their International Business Development Manager, where he works to bring their products into the livestock health markets globally.
He continues to offer sheep advisory services to farmers and teach students, and recently supported APHA as an OV during the current BTV-3 outbreak.
On being named the winner, David said: “I was stunned to even be nominated for this prestigious award, let alone win it!
"I am absolutely delighted and humbled at the same time.
"My career has been a real journey of ups and downs so far, but I’ve overcome the challenges in my way and have had the chance to undertake and create several different opportunities since having to step away from full-time clinical work.
"I hope to do this award justice and to inspire other young vets who may also be going through difficult times to rise to the challenge and embrace the varied opportunities our profession offers.
"Congratulations to my fellow finalists too.”
Other award winners included Axe Valley Large Animal Vets, Old Golf House Vets and The University of Central Lancashire - School of Veterinary Medicine, which all took a BVA Wellbeing Award for having embraced the Association's Good Veterinary Workplaces initiative and created inclusive workplaces with positive cultures where staff feel valued.
Paula Boyden, Veterinary Director at Dogs Trust, won the BVA Outstanding Service Award (Chiron Award) for services to the profession.
Eddie Clutton, Clinical Director of the Wellcome Trust Critical Care Laboratory for Large Animals (Roslin Institute), won the BVA Advancement of Veterinary Science Award (Dalrymple-Champneys Cup and Medal) for his distinctive contributions to the field of veterinary anaesthesia.
The company says both programmes will be delivered using a range of high-quality blended learning techniques, including interactive online lessons supported by notes and videos.
The Small Animal Surgery programme will offer ten practical sessions held at training centres.
Delegates for Improve’s new DL Certificate programmes get both a module tutor – a recognised Specialist - and a dedicated programme tutor to support them through the course.
Alison Babington MRCVS, Business Development Coordinator at Improve International (pictured right), said: "We recently set out our strategy to make the achievement of a postgraduate qualification a realistic goal for every veterinarian and the launch of these new DL programmes will help us to deliver on this goal. Our DL Small Animal Medicine Certificate was launched in January 2019 and has attracted veterinarians from around the world, who are keen to study for a programme in their own time at a place of their choosing.”
“The new DL Small Animal Surgery course focuses on soft tissue surgery in the first year and orthopaedics and spinal work in the second. Reflecting the latest thinking and techniques for small animal surgery, it offers an excellent platform for surgeons keen to extend their surgical capabilities. High-quality surgical videos will support every module which delegates will have access to throughout their programme.
“The Feline Practice programme offers an in-depth look at some of the more common medical and surgical issues affecting cats, as well as those which can be more challenging to diagnose and treat.”
Delegates for both programmes have the opportunity to progress to achieving a recognised qualification, General Practitioner Certificate (GPCert) or a Postgraduate Certificate (PgC).
To register, visit: https://www.improveinternational.com/uk/distance-learning.
Boehringer Ingelheim has announced that its 'Talk About Laminitis' campaign will run from Mid March until the end of June.
Last year, the initiative saw over 9000 horses and ponies tested for PPID through its free ACTH test scheme. This year, to build on this success and support the testing of even more animals, the company has announced a high impact, co-ordinated campaign to drive awareness that up to 90% of laminitis cases may have an underlying endocrine cause1,2.
Once again, Boehringer is urging veterinary surgeons to carry out free ACTH blood tests on laminitic or foot-sore horses as part of the campaign, which is backed by Redwings, The British Horse Society and World Horse Welfare.
Professor Andy Durham from the Liphook Equine Hospital, where the ACTH tests are performed, said: "We are learning so much from these tests. For example, we are now recognising PPID routinely in laminitic horses and ponies as young as 10 years old, and in the spring when we might expect to see more EMS cases, where veterinary surgeons have also tested for PPID we are seeing both abnormally elevated ACTH and insulin. Unless the PPID is addressed, horses will continue to be at risk of painful recurrent laminitic episodes which is a significant welfare issue to the horse and extremely frustrating for owners."
To participate in the scheme, veterinary surgeons and horse owners can download ACTH blood test vouchers from www.talkaboutlaminitis.co.uk. Attach the voucher to the ACTH sample submission form and the ACTH laboratory fees will not be charged.
Lee Hackett from The British Horse Society said: "Without the 'Talk About Laminitis' initiative and the support of Boehringer Ingelheim, literally thousands of horses may not be receiving the appropriate treatment and management for their laminitis to help prevent recurrence. We hope as many veterinary surgeons as possible get involved this year to continue this welfare success."
To ensure that horse owners are fully aware of the initiative, a PR and advertising campaign in the equine consumer media will start in March. The ad campaign includes an infomercial on Horse & Country TV (SKY Channel 280), with viewer numbers in excess of 450,000 per month.
There will also be a live online broadcast for horse owners on endocrinopathic laminitis presented by David Rendle BVSc MVM CertEM(IntMed) DipECEIM MRCVS, from the Liphook Equine Hospital in Hampshire. The one-hour webinar, which takes place at 8.00pm on Wednesday 10 April, will educate horse owners on how the veterinary profession's understanding of this debilitating and devastating disease has been completely revolutionised over the past five years. It will be followed by an interactive Q&A session when viewers will be able to pose questions for David to answer.
David said: "As our knowledge of the two hormonal diseases responsible for the majority of cases of laminitis improves, veterinary surgeons can offer their clients more comprehensive advice on treatment options to prevent laminitis. For many owners who have struggled with this condition, this is an absolute revelation and has enormous welfare benefits".
Horse owners can register to view the online programme by visiting www.talkaboutlaminitis.co.uk.
To ensure that veterinary surgeons are versed in the most up to date research available, Boehringer Ingelheim will also be hosting a webinar for veterinary professionals at 8.00pm on Wednesday 13th March, presented by Professor Andy Durham BSc BVSc CertEP DEIM DipECEIM MRCVS. The online seminar, 'The laminitis revolution.... An update on our understanding of endocrinopathic causes of laminitis', will entitle the viewer to a downloadable certificate for one hour of CPD. To register, visit www.bi-academy.co.uk. Places are limited, so register early to avoid disappointment. The webinar will also be available to view after the event on demand.
For further information on how you can promote 'Talk About Laminitis' in your practice contact your Boehringer Ingelheim Territory Manager or call 01344 746959
References
1. Karikoski et al. (2011). The prevalence of endocrinopathic laminitis among horses presented for laminitis at a first-opinion/referral equine hospital. Domestic Animal Endocrinology 41 111-117
2. Donaldson et al. (2004). Evaluation of suspected pituitary pars intermedia dysfunction in horses with laminitis. J Am Vet Med Assoc;224:1123-1127.
Ceva Animal Health has launched a new travel size 20ml bottle of Feliway Spray to help cat owners keep their pet comfortable whilst travelling this summer.
To promote the launch Ceva is giving away thousands of prizes to Feliway customers, offering them the chance to win a top prize of a spa day at Champneys, cat carriers, soft toys and travel stickers, whilst stocks last. To take part, customers need to enter their unique pack code via the Feliway Facebook page to toss an online coin to see what they have won.
In addition, veterinary surgeries that purchase a 12 pack of the 20ml spray will get a second 12 pack free.
Julia Wood, product manager at Ceva said: "Transporting cats even short distances, for necessary trips to the vet, cattery or to a local show, can easily become a nightmare for both the cat and the owner. We've introduced the new travel size spray to make it even more convenient for cat owners when they are on the move and we hope the extra competition incentive will drive sales for veterinary clinics."
Virbac has announced that it will repeat its EasOtic promotion through which practitioners that make multiple purchases of the award-winning otitis treatment can claim an ear model and specialist ear instrument kit.
The models, which show the anatomy of a healthy canal on one side and the changes associated with chronic damage on the other, are approximately 15cm high and can be used as a visual aid to show clients the consequences of untreated chronic ear disease.
The specialist ear instrument kits, worth £100, have been designed in consultation with veterinary dermatologists. They consist of a haemostat, ear forceps, three various cerumen scoops and a Spreulls ear-flushing needle.
Product Manager Chris Geddes MRCVS said: "Basically it's the best ear equipment for daily use by practitioners. Last year we were overwhelmed by the demand of both promotions, so we've decided to repeat the offer again this year."
The models and kits are available with multiple purchases of EasOtic and the neutral pH glycotechnology ear cleaner Epi-Otic.
For details of how you can obtain a model and/or kit for your practice contact your local Virbac territory manager or call Virbac on 01359 243243.
Dechra Veterinary Products has launched a webcast about feline hyperthyoidism, given by Tim Williams MA VetMB MRCVS from the Feline Research Group at the Royal Veterinary College.
During the ten minute webcast, entitled: 'The highs and lows of feline hyperthyroidism', Tim presents new evidence that overdosing hyperthyroid patients can lead to iatrogenic hypothyroidism, making them more likely to develop azotaemia and consequently have a shorter survival time. He also discusses the diagnosis and potential consequences of iatrogenic hypothyroidism based on recent research conducted at the Feline Research Group, and provides a summary of suggested treatment protocols. Tim said: "I hope the webcast helps veterinary staff optimise their treatment of hyperthyroid cats in practice and avoid a one size fits all approach".
Dechra says that research from 400 first opinion practices has shown that hyperthyroidism is the most commonly diagnosed feline endocrinopathy, with an annual incidence of 6% in cats over nine years old.
Tim's webcast is the latest in a series of online educational materials on endocrinology launched by Dechra as part of its Dechra Academy training suite.The webcast is available at http://www.dechra.co.uk/hyperthyroidism
The practice was officially opened by the TV presenter and newspaper columnist, Adrian Chiles, who faced a lot of criticism from the profession a couple of years ago when he wrote an article about increasing veterinary fees and upselling tactics.
Adrian said: “I have never received such a volume of correspondence to one of my newspaper columns.
"One of the people that wrote to me was Movement Director, Professor John Innes, and we had very useful subsequent discussions that made me realise I had unfairly blamed vets for the issues I had felt as a pet owner.”
The new centre is led by Mark Lowrie, Specialist veterinary neurologist, who is joined by orthopaedic surgeons, Kinley Smith and David Thomson and neurology residents, Callum Golding and Rebecca Clark.
https://www.movementvets.co.uk
Nutramega contains omega-3 fatty acids, specifically EPA and DHA, which the company says are critical for the overall health of animals, with many health benefits, including joints & mobility, skin & coat, heart health, the kidneys and brain health.
Nutramega comes in two sizes, 100ml and 200ml, with prices starting from £20.00.
Pet Ready LifeStages are health chews designed to provide daily support for puppies, adult dogs and senior dogs.
Each LifeStage product comes in 30 and 90 chew packets and prices range from £19.99 to £34.99.
www.nutravet.co.uk
Delivered in a case-based style, the course will give students the chance to work through cases and apply practical theory before treating feline patients.
There are four modules: the consultation, further investigations, treatment, and post-operative and preventative care.
ICC says the emphasis is on providing practical skills that can be used in clinic.
On completion, students will have the confidence to identify a range of dental abnormalities, persuade cat owners to consent to further investigation and treatment, and formulate and carry out the ideal treatment plan for each cat.
Dr. Matthew Oxford BVM&S GPCert(SAS) MRCVS, who helped develop the course, said: "Dentistry is poorly represented in undergraduate veterinary courses, with feline specific dentistry perhaps only having one or two lectures, yet dentistry accounts for roughly 25% of all general surgery.
"This transformational course uses a very practical approach to case management taking vets from the initial consultation, through anaesthesia, dental radiography, surgery, and then postoperative care.
"Cases are worked through with extensive teaching material supplemented into cases to provide a pragmatic, case-based approach.”
Pre-registration for the course is available until 1st November with an early bird price of £299 (+VAT) available using the discount code NEWCBL50 at the checkout.
For more information, to check eligibility and prerequisites, and to sign up, visit https://bit.ly/3GpFXo4
Animalcare has announced that Buprecare buprenorphine single dose ampoules are now back in stock and ready to order from all veterinary wholesalers.
Production of the product had ceased in July 2011, when the company's previous manufacturer closed its sterile production unit.
Animalcare says that since then, it has been working to identify a reliable, high quality manufacturer which will be able to meet demand. The company has now signed a new contract with a German company which operates a substantial sterile injectables manufacturing facility in France. This facility is approved to manufacture Buprecare single dose ampoules and has produced, tested, quality assured and shipped its first batches.
Stephen Wildridge, CEO of Animalcare Group plc, said: “It was very disappointing to lose our marketing leading product Buprecare ampoules so abruptly. However after some excellent work from the Animalcare team in identifying and working with a very competent manufacturer we are now back in a market that has been eagerly awaiting our return and with a supplier that puts us in an even stronger position. It’s a very good way to start 2013.”
Available in the familiar 5 x 1ml pack, the Buprecare single dose ampoules now have a ‘one-point-cut’ design giving greater assurance of a clean ‘snap’ when opening the ampoule, enhancing the safety of the user.
Additional support is also now available to veterinary practices that purchase Buprecare ampoules or multidose vials, including CPD pain management talks and a peer-reviewed pain assessment chart.
The British Small Animal Veterinary Association has announced that it is offering a new, enhanced legal service for its members, in conjunction Harrison Clark Rickerbys.
From 1st October, BSAVA members will be able to benefit from discounted rates and special fixed-fee packages for their personal and professional legal needs.
The BSAVA says that Harrison Clark Rickerbys' specialist team has a vast experience of acting for small animal veterinary practices, as well as referral practices and animal hospitals throughout the UK.
Charlotte Thornton-Smith from Harrison Clark Rickerbys said: "The team is delighted to provide dedicated membership benefits to the BSAVA and keen to work with its members to advise on any of their legal issues. We have a longstanding relationship with the BSAVA which stretches back over twenty years and have substantial experience of acting for veterinary practitioners, both personally and professionally. We very much hope that members of the BSAVA will take advantage of the special packages and discounted rates we are offering."
For more information, visit www.bsava.com
Virbac - manufacturer of Effipro - has launched the 'Flea Free Zones' campaign to help practices fight back against retail competition in the flea control market.
The company says that with an on-pet flea product market estimated to be worth well in excess of £64 million, and an estimated 20 million cats and dogs in the UK, vets are well positioned to improve their revenues and provide excellent customer service, by promoting flea control to all of their customers.
However, according Dr Rachel Crowe, Effipro Product Manager, much of this business is currently going through retail channels: "Many pet owners have become used to purchasing their flea treatment from retail outlets, mainly due to cost, and no longer distinguishing between a brand bought from a vet and one bought from a supermarket.
"As a dedicated veterinary business, Virbac is focussed on supporting and increasing business within veterinary practices. Our 'Flea Free Zones' campaign is a practice support package designed to help promote initial purchase, as well as long-term client loyalty. We know that pet owners often turn to their vet or vet nurse for advice, but then purchase treatments elsewhere.
"With Effipro, practices have the performance of fipronil but at a highly affordable price, and we believe this promotion will help vets grow their share of the flea control market."
The campaign is designed to get clients purchasing flea treatments from their vet and encourage repeat purchases from the practice.
Dr Crowe said: "The beauty of Effipro is that it has a broad range of products, packs and price flexibility. In particular the single pipette from the Practice Pack is proving a very popular point of entry for the owner, especially as an initial trial purchase. Also included in the promotional campaign is an Effipro loyalty scheme, which provides an incentive to keep clients coming back and literature to assist practice staff to answer customer queries about flea control.
"Just one spot-on treatment range also means there is no confusion with POM-V alternatives, so loyalty to Effipro is easier to retain within the practice. And with the added option of purchasing award winning Indorex environmental insecticide spray, clients now have a complete flea control solution available from their vet practice. So with both products being supported by prominent promotional campaigns, there hasn't been a better opportunity than this for vets looking to capture a bigger share of customer spend on flea treatments."
To learn more about Virbac's Flea Free Zones campaign contact your local Virbac territory manager or call Virbac on 01359 243243.
BEVA Congress 2021 will now take place from September 4th-7th 2021.
The decision to cancel Congress 2020 was taken by BEVA Council and the Congress programme committee because of the unpredictable circumstances of the coronavirus pandemic.
Tim Mair, President of BEVA said: “The overriding factor in our decision-making process was to protect everyone attending Congress. We are chartering unknown territory at the moment and the additional planning requirements needed to run a large event like BEVA Congress with social distancing measures in place will take time.
“We intend for September 2021 to mark an exciting, fresh start for the profession following the harrowing experiences of 2020. It should be safe for our international speakers and delegates to attend by then, getting us all back on track with networking and world-class CPD to inspire us for the new post Covid-19 world.”
Tickets for BEVA Congress 2021 will be available later this year, more information from: www.bevacongress.org.
The guidance has been in place since March to help practices continue to provide the public with veterinary services whilst safeguarding the health of their teams and clients.
The RCVS Council Covid-19 Taskforce reviewed the situation on 30th July and decided to extend the guidance after taking into account the pandemic’s progress, the latest government guidance, the headline results from a survey of practice experience of remote consulting, and 'other data from a number of veterinary practices'.
The Taskforce says it also considered the need to continue to provide practices with flexibility in the face of possible local or national lockdowns, the need for inclusivity of those practice teams members and clients who may still be shielding, the likelihood of quarantine of members of the team due to travel and/or Test and Trace and the fact that no major safety issues had been identified as part of the RCVS-commissioned survey into the immediate impact of the temporary guidance.
RCVS President Mandisa Greene, who chairs the Taskforce, said: “Whilst lockdown measures have been eased and matters have improved, we are far from being back to business as usual and the threat of returning to more severe lockdown measures, whether locally or nationally, is still very much alive."
The updated flowchart, along with all the College’s coronavirus guidance for the professions, is available at: www.rcvs.org.uk/coronavirus.
2021’s event will see over 70 hours of CPD across eight themes, with speakers including Megan Brashear and Helen Wilson, clinical lead for ECC at Langford Vets, University of Bristol.
RCVS President Mandisa Greene will open Congress with reflections from the past year. She'll be followed by the keynote speaker, Marie Holowaychuk, who will be sharing her knowledge and experience around health and wellbeing.
Dan Lewis – ECC specialist at Vets Now, who planned the veterinary Congress programme, said: “In 2020, the world of live events changed, and in November we delivered our first ECC virtual Congress to great success.
"Not only do we feel it is the right decision for everyone to continue our ECC Congress as a virtual event, but the format brings a huge number of opportunities for delegates, exhibitors and speakers, who joined us from all across the world.
"The interactive platform we’re using is cutting edge and it provides so much more than just webinars. Like last year, there will be live content, an interactive exhibition hall and more opportunities than ever for delegates to network and learn from some of the world’s leading veterinary experts discussing emergency and critical care.
"Our programme again this year has been carefully tailored to provide an inclusive learning experience for vets and vet nurses no matter what stage they’re at in their career, from students through to specialists.
"All being well, we will be back in Leeds for the ECC Congress in November 2022.” Full four-day tickets for delegates will range in price from £60 to £199 and ticket-holders will be able to access all the sessions on-demand for up to a month following the event.
To book your ticket, visit congress.vets-now.com
The company says it is a further step forward in its plans to expand into Europe and follows the launch of its online pharmacy business, Animed Direct, into France during 2016. It adds that further acquisitions are expected in Europe during 2017, in addition to continued growth in the UK.
The two Dutch practices joining CVS are the Kliniek voor Gezelschaps Dieren, a three site small animal practice based in the central Netherlands, and a single site small animal practice, Dierenziekenhuis Drachten, based in the north of the country. Both practices cited the business support and staff development opportunities offered by CVS, combined with the clinical freedom and practice autonomy it allows, as the reasons for choosing to join the company.
Simon Innes, CEO at CVS, said: "We see many parallels between small animal practice in the Netherlands and the UK and have been talking to practices in the country about the benefits of joining us for some time. The level of interest has been encouraging and we are delighted to announce the acquisition of these two practices and welcome their teams to the CVS family.
"During 2017, we will continue to explore opportunities to extend our activities into Europe, particularly in the Netherlands and in Ireland."
The Society of Practising Veterinary Surgeons (SPVS) reports that its annual Congress, held jointly with the Veterinary Practice Managers Association (VPMA) at the Celtic Manor Resort in Newport last week, was a sell out.
Over 470 delegates attended, of which 40% were practice owners, 40% were vets, 30% were practice managers and 10% were nurses.
Held over two days, the line-up of speakers included TV presenter, expedition leader, leadership trainer and ex-Royal Marine, Monty Halls who opened Congress with a talk on the importance of pushing your own personal boundaries. Psychiatrist, broadcaster and journalist, Dr Max Pemberton presented a guide to mental health problems for vets and managers. Celtic Manor’s head of 5 Star Service Delivery, Michael Pagnotta, explained how they ensure all their staff operate to the same consistently high level of service provision and Ian McKelvie, CEO of US consultancy, Becauz, presented a number of leadership and management sessions.
VetSurgeon.org visited the commercial exhibition and ask a random selection of exhibitors: "What's New?"
This is what they said:
New research amongst veterinary professionals conducted by CEVA Animal Health, manufacturer of D.A.P.® and Feliway®, has revealed that pet owners may be unintentionally fuelling their pets' noise phobias in the run up to the fireworks' season.
According to CEVA's research, up to 95% react inappropriately, for example petting an anxious pet during firework exposure rather than making an effort to ignore the fireworks, thereby reassuring the animal by behaving normally.
The research also suggested that 77% of clients have never taken action to address their pets' noise phobias as fireworks' season is only an annual occurrence. This is despite evidence that noise phobias can affect pets all year round and tend to become worse over time.
In addition, if owners do seek advice from their vet for noise phobias, it is at the last minute. It is estimated that 46% of clients leave it until the day before the fireworks are due to start before seeking help.
Lucy Brett, product manager at CEVA Animal Health said: "Owners are not doing enough to reduce their pets' firework fears and prevent noise phobias from developing.
"Taking early, proactive action within the practice is the best way to help dogs with pre-existing firework phobias as well as those with mild fears which, if left untreated, may develop into more serious noise phobias."
CEVA Animal Health and Sound Therapy 4 Pets have once again joined forces with the Association of Pet Behaviour Counsellors (APBC), Feline Advisory Bureau (FAB) and PDSA to launch a 'Remember, remember your pets this November' campaign to provide owners with advice on how to look after their pets during the firework season and the precautions they should take to help them cope with their fear of fireworks.
The initiative features a wide range of advice including how to use synthetic copies of natural pheromones, D.A.P. ® and Feliway®, to help comfort and reassure fearful pets, creating a comforting den for dogs to retreat to during firework exposure and treating noise phobias using behavioural therapy with the Sounds Scary desensitisation CD (which is the only behavioural therapy product for noise phobias supported by the RSPCA).
For further information, please visit www.petfireworkfear.co.uk.
This brings the total number of oncology specialists to four, within a service comprising 12 oncology professionals.
After getting her bachelor’s degree in biology from Duke University, Sarah (pictured right) enrolled at the University of Pennsylvania School of Veterinary Medicine, from which she graduated summa cum laude (with highest honours) in 2017.
Sarah stayed on at Penn to complete an internship in small animal medicine and surgery followed by a residency in medical oncology.
She became a diplomate of the American College of Veterinary Internal Medicine in 2021 and joined the team at Davies in October 2021.
Sarah said: “I joined Davies for the opportunity to collaborate with specialists spanning all aspects of veterinary medicine.
“This allows me to provide the best care for my patients and contribute to the future of veterinary medicine.
"It is a privilege to work with so many kind, motivated and intelligent individuals that share these same goals.”
The training will take place in locations across BSAVA’s regional network in the UK, and is open to large, small, and equine veterinary teams.
The sessions will cover the complexity of abuse and the impact of domestic abuse on children, how to recognise abuse/non-accidental injury in animals, how to document information and what to do when dealing with disclosure from a human victim of abuse.
They will also give guidance on setting up a practice protocol and identifying a practice links adviser who will assist those involved in the veterinary team to manage suspected cases of abuse.
Invited guests will include representatives from human and veterinary health, welfare bodies and policy makers.
Vicki Betton, Vice-Chair of The Links Group said: “We’re thrilled to be rolling out our programme of in-person training days with BSAVA.
"Abuse of any vulnerable member of the family, human or animal, is a difficult subject for many to even consider, but with reported cases of domestic abuse reaching an all-time high during the pandemic, its essential that teams are aware of the issue and have a practice protocol in place for if they feel something isn’t quite right with a case.
“We’re looking forward to exploring the most effective ways veterinary teams can recognise and act on suspected cases of non-accidental injury or disclosures of domestic or child abuse.”
The training days are free for BSAVA members and £50 (inc VAT) for non members.
So far, dates have been confirmed for Nottingham on 18th April and Exeter on the 29th June. Others are planned for the Metropolitan, Southern, Wales and North West regions.
To book your place, visit: https://www.bsava.com/education/cpd/regional-cpd
Boehringer Ingelheim has released details of research presented at the 29th World Veterinary Congress which shows dogs with congestive heart failure (CHF) due to myxomatous mitral valve disease (MMVD) live longer when treated with pimobendan (Vetmedin®) compared with a commonly used ACE inhibitor.
The results of the QUEST trial, the largest international study of its kind to be conducted amongst dogs with congestive heart failure, are due to be published in the Journal of Veterinary Internal Medicine (JVIM) later this year.
The condition myxomatous mitral valve disease (MMVD) accounts for approximately 75% of all cases of CHF in dogs2. MMVD is associated with the thickening of the cusps of the mitral valve (one of the main one-way valves within the heart), affecting the flow of blood from the heart to the rest of the body. Although there is no cure for CHF due to MMVD, there are treatments available to manage the condition, improving the quality and length of the dog's life.
Professor Jens Häggström, lead investigator of the QUEST trial from the University of Uppsala, Sweden, commented that "the QUEST trial is a significant milestone in our efforts to reassure both, veterinarians and dog owners, that there is compelling evidence to show that pimobendan is an effective treatment for CHF that prolongs their dog's life and providing pet and owner with more quality time together."
The QUEST trial was a randomised, positive-controlled, multi-centre trial conducted at 28 sites across 11 countries, and is the largest study of its kind ever conducted in veterinary cardiology. The study compared a pimobendan group with a group treated with benazepril hydrochloride on top of background diuretic therapy. The trial spanned three years and followed dogs to death, euthanasia or treatment failure leading to withdrawal from the trial.
Research by Boehringer has also shown that over 50% of dog owners in the UK are unaware that their dog may be at risk of heart failure. Heart disease affects one in four dogs over seven years of age, and the lack of knowledge about this serious, life-threatening condition suggests that there is a need for better education amongst dog owners on how to recognise the disease, and how to maintain their dogs' heart health.
The questionnaire asks you about your perceptions of the PDP, with a focus on the guidance made available both by the RCVS and where applicable the resources provided by the BSAVA.
The company stresses that the survey is confidential, and results will be reported in aggregate only; no individual will be identified. It takes 5 minutes and the results will be used to help evaluate and improve the PDP in the future.
Graduates who are currently or have recently completed the PDP are invited to share their views on the PDP: http://app.keysurvey.co.uk/f/1141621/9038/
Employers / mentors of veterinary graduates are invited to share their views on the PDP here: http://app.keysurvey.co.uk/f/1141665/288d/
Vetsonic has announced the launch of a tablet form of Arthriaid Omega.
Designed to support joint health, the nutraceutical product contains glucosamine, chondroitin, omega 3 fatty acids, MSM, manganese sulphate plus vitamins C and E.
This new tablet form joins the existing range of palatable liquids, chews, cat gel and the original ArthriAid tablets and ArthriAid HA powder, which will continue to be available.
The survey, which is being carried out throughout June, was also conducted back in 2016 and is now being repeated to identify any developments and outcomes that have been made over the past four years, a time in which several new epilepsy management options have emerged.
The survey asks vets to prioritise how important they feel different areas of epilepsy research are and assess how much they think new therapies might improve epileptic dogs’ lives. This includes emerging therapies like MCT oil, cannabidiol oil, vagus nerve stimulation and transcranial magnetic stimulation, for which studies are currently being conducted across the globe.
The aim of the survey is to identify the priorities for future research for owners, vets and neurologists alike, and to see if there are any differences in their priorities.
Dr Rowena Packer, BBSRC Research Fellow and research lead in canine epilepsy at the RVC, said: "This survey was inspired by similar prioritisation activities undertaken by the International League Against Epilepsy (ILAE) for human epilepsy patients. At the RVC, we believe that the benefits of such an open approach can be truly valuable for veterinary medicine too, and ensure a diversity of views influence future epilepsy priorities."
Dr Gareth Jones, Small Animal Intern at the RVC who is running the study, said: "While many have already undertaken the survey, we are keen to hear from more participants so I would like to implore any general practice vets to please help contribute to our work by taking part in our short survey."
To take part in this survey please visit www.rvc.uk.com/epilepsy-future, and do share this news story with colleagues. If you have any questions about the research, e-mail Dr Gareth Jones atgjones1@rvc.ac.uk.